Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)

Next Previous
Trial Profile

A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2018

At a glance

  • Drugs TMS 007 (Primary)
  • Indications Cerebral infarction; Stroke
  • Focus Adverse reactions
  • Sponsors TMS

    • Most Recent Events

    • 07 Jun 2018 According to a Biogen media release, the first patient has been dosed in Feb 2018 in this study.
    • 08 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top